RPS6KB1 and neoplasm: The fact that combined inhibition of PI3K and mTOR signaling did not further improve IL-12p70 secretion by DC-tumor fusions may indicate that inhibition acted on the same signaling pathway, likely to involve p70S6K as has been described previously [49].